Metabolic dysfunction-associated steatotic liver disease: an emerging comorbidity in COPD.

Saved in:
Bibliographic Details
Title: Metabolic dysfunction-associated steatotic liver disease: an emerging comorbidity in COPD.
Authors: Al Dailaty A; Department of Internal Medicine, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon.; Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon., Ghanem A; Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon., Abou Daher G; Department of Internal Medicine, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon.; Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon., Chaaban T; Department of Internal Medicine, Lebanese American University Medical Center-Rizk Hospital, P.O. Box 11-3288, Beirut, Lebanon.; Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Medical Center, Byblos, Lebanon., Chatila R; Department of Internal Medicine, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon.; Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon.
Source: Therapeutic advances in chronic disease [Ther Adv Chronic Dis] 2025 Sep 27; Vol. 16, pp. 20406223251378868. Date of Electronic Publication: 2025 Sep 27 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 101532140 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6223 (Print) Linking ISSN: 20406223 NLM ISO Abbreviation: Ther Adv Chronic Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2040-6223
DOI:10.1177/20406223251378868